BMP-7 and bone regeneration

Evaluation of dose-response in a rodent segmental defect model

Joel C. Williams, Sukanta Maitra, Matthew J. Anderson, Blaine A Christiansen, A Hari Reddi, Mark A Lee

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives: To develop and validate a translatable and reproducible rodent critical-sized defect (CSD) model and to determine the optimal dose of recombinant human bone morphogenetic protein (BMP)-7 required to consistently heal the CSD in the new model. Methods: Rats with 6-mm CSDs stabilized with a commercial radiolucent plate and screws with angular stability were randomly assigned to 4 treatment groups with varied doses of recombinant human BMP-7 (25, 50, 75, and 100 g) on absorbable collagen sponge and a single control group (absorbable collagen sponge alone). Bone formation was evaluated by radiographs, micro-computed tomography, histology, and biomechanics. Results: All the rats treated with 100 g of BMP-7 with CSDs were united by 4 weeks and all 75- and 50-g-group rats united by 6 weeks. None of the animals in the 25-g BMP-7 group or the control group were healed at the time of killing. Bone volume, bone mineral density, the ratio of bone volume to total volume, stiffness, and ultimate load to failure were maximal in the 50-g group. Total callus volume progressively increased with increasing BMP dose. Histologic analysis demonstrated increased callus width with increasing BMP-7 doses above 50 g, but the bone seemed structurally abnormal. Conclusions: There was a 100% union rate in the 50-, 75-, and 100-g BMP-7-treated groups. None of the control or 25-g-dose rats united. The biomechanical data demonstrated that 50 g of BMP-7 produced the highest mechanical strength in the bone regenerate. These data also suggest that administration of BMP-7 above 50 g does not improve bone regeneration and actually seems to produce lower quality bone with diminished biomechanical properties.

Original languageEnglish (US)
Pages (from-to)e336-e341
JournalJournal of Orthopaedic Trauma
Volume29
Issue number9
DOIs
StatePublished - Sep 22 2015

Fingerprint

Bone Morphogenetic Protein 7
Bone Regeneration
Rodentia
Bone and Bones
Bony Callus
Porifera
Collagen
Control Groups
Bone Morphogenetic Proteins
Biomechanical Phenomena
Osteogenesis
Bone Density
Histology
Tomography

Keywords

  • animal model
  • bone morphogenic protein
  • bone regeneration
  • segmental defect
  • trauma

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

BMP-7 and bone regeneration : Evaluation of dose-response in a rodent segmental defect model. / Williams, Joel C.; Maitra, Sukanta; Anderson, Matthew J.; Christiansen, Blaine A; Reddi, A Hari; Lee, Mark A.

In: Journal of Orthopaedic Trauma, Vol. 29, No. 9, 22.09.2015, p. e336-e341.

Research output: Contribution to journalArticle

@article{e88a738e8a63413697dfeb53c8f03835,
title = "BMP-7 and bone regeneration: Evaluation of dose-response in a rodent segmental defect model",
abstract = "Objectives: To develop and validate a translatable and reproducible rodent critical-sized defect (CSD) model and to determine the optimal dose of recombinant human bone morphogenetic protein (BMP)-7 required to consistently heal the CSD in the new model. Methods: Rats with 6-mm CSDs stabilized with a commercial radiolucent plate and screws with angular stability were randomly assigned to 4 treatment groups with varied doses of recombinant human BMP-7 (25, 50, 75, and 100 g) on absorbable collagen sponge and a single control group (absorbable collagen sponge alone). Bone formation was evaluated by radiographs, micro-computed tomography, histology, and biomechanics. Results: All the rats treated with 100 g of BMP-7 with CSDs were united by 4 weeks and all 75- and 50-g-group rats united by 6 weeks. None of the animals in the 25-g BMP-7 group or the control group were healed at the time of killing. Bone volume, bone mineral density, the ratio of bone volume to total volume, stiffness, and ultimate load to failure were maximal in the 50-g group. Total callus volume progressively increased with increasing BMP dose. Histologic analysis demonstrated increased callus width with increasing BMP-7 doses above 50 g, but the bone seemed structurally abnormal. Conclusions: There was a 100{\%} union rate in the 50-, 75-, and 100-g BMP-7-treated groups. None of the control or 25-g-dose rats united. The biomechanical data demonstrated that 50 g of BMP-7 produced the highest mechanical strength in the bone regenerate. These data also suggest that administration of BMP-7 above 50 g does not improve bone regeneration and actually seems to produce lower quality bone with diminished biomechanical properties.",
keywords = "animal model, bone morphogenic protein, bone regeneration, segmental defect, trauma",
author = "Williams, {Joel C.} and Sukanta Maitra and Anderson, {Matthew J.} and Christiansen, {Blaine A} and Reddi, {A Hari} and Lee, {Mark A}",
year = "2015",
month = "9",
day = "22",
doi = "10.1097/BOT.0000000000000307",
language = "English (US)",
volume = "29",
pages = "e336--e341",
journal = "Journal of Orthopaedic Trauma",
issn = "0890-5339",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - BMP-7 and bone regeneration

T2 - Evaluation of dose-response in a rodent segmental defect model

AU - Williams, Joel C.

AU - Maitra, Sukanta

AU - Anderson, Matthew J.

AU - Christiansen, Blaine A

AU - Reddi, A Hari

AU - Lee, Mark A

PY - 2015/9/22

Y1 - 2015/9/22

N2 - Objectives: To develop and validate a translatable and reproducible rodent critical-sized defect (CSD) model and to determine the optimal dose of recombinant human bone morphogenetic protein (BMP)-7 required to consistently heal the CSD in the new model. Methods: Rats with 6-mm CSDs stabilized with a commercial radiolucent plate and screws with angular stability were randomly assigned to 4 treatment groups with varied doses of recombinant human BMP-7 (25, 50, 75, and 100 g) on absorbable collagen sponge and a single control group (absorbable collagen sponge alone). Bone formation was evaluated by radiographs, micro-computed tomography, histology, and biomechanics. Results: All the rats treated with 100 g of BMP-7 with CSDs were united by 4 weeks and all 75- and 50-g-group rats united by 6 weeks. None of the animals in the 25-g BMP-7 group or the control group were healed at the time of killing. Bone volume, bone mineral density, the ratio of bone volume to total volume, stiffness, and ultimate load to failure were maximal in the 50-g group. Total callus volume progressively increased with increasing BMP dose. Histologic analysis demonstrated increased callus width with increasing BMP-7 doses above 50 g, but the bone seemed structurally abnormal. Conclusions: There was a 100% union rate in the 50-, 75-, and 100-g BMP-7-treated groups. None of the control or 25-g-dose rats united. The biomechanical data demonstrated that 50 g of BMP-7 produced the highest mechanical strength in the bone regenerate. These data also suggest that administration of BMP-7 above 50 g does not improve bone regeneration and actually seems to produce lower quality bone with diminished biomechanical properties.

AB - Objectives: To develop and validate a translatable and reproducible rodent critical-sized defect (CSD) model and to determine the optimal dose of recombinant human bone morphogenetic protein (BMP)-7 required to consistently heal the CSD in the new model. Methods: Rats with 6-mm CSDs stabilized with a commercial radiolucent plate and screws with angular stability were randomly assigned to 4 treatment groups with varied doses of recombinant human BMP-7 (25, 50, 75, and 100 g) on absorbable collagen sponge and a single control group (absorbable collagen sponge alone). Bone formation was evaluated by radiographs, micro-computed tomography, histology, and biomechanics. Results: All the rats treated with 100 g of BMP-7 with CSDs were united by 4 weeks and all 75- and 50-g-group rats united by 6 weeks. None of the animals in the 25-g BMP-7 group or the control group were healed at the time of killing. Bone volume, bone mineral density, the ratio of bone volume to total volume, stiffness, and ultimate load to failure were maximal in the 50-g group. Total callus volume progressively increased with increasing BMP dose. Histologic analysis demonstrated increased callus width with increasing BMP-7 doses above 50 g, but the bone seemed structurally abnormal. Conclusions: There was a 100% union rate in the 50-, 75-, and 100-g BMP-7-treated groups. None of the control or 25-g-dose rats united. The biomechanical data demonstrated that 50 g of BMP-7 produced the highest mechanical strength in the bone regenerate. These data also suggest that administration of BMP-7 above 50 g does not improve bone regeneration and actually seems to produce lower quality bone with diminished biomechanical properties.

KW - animal model

KW - bone morphogenic protein

KW - bone regeneration

KW - segmental defect

KW - trauma

UR - http://www.scopus.com/inward/record.url?scp=84940206302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940206302&partnerID=8YFLogxK

U2 - 10.1097/BOT.0000000000000307

DO - 10.1097/BOT.0000000000000307

M3 - Article

VL - 29

SP - e336-e341

JO - Journal of Orthopaedic Trauma

JF - Journal of Orthopaedic Trauma

SN - 0890-5339

IS - 9

ER -